Aesthetic manufacturer mesoestetic has launched the mesohyal redenx skin booster.
The manufacturer shares that the booster aims to target moderate ageing, loss of density and sagging of the skin, and is designed to support skin regeneration, extracellular matrix reorganisation and long-lasting hydration through a non-inflammatory pathway.
mesoestetic outlines that mesohyal redenx is formulated with a combination of biomimetic peptides and biorevitalising ingredients designed to mimic the body’s natural signalling processes, helping to stimulate collagen production, enhance skin repair and improve firmness and vitality.
The treatment is administered intradermally and is particularly recommended for the lower third of the face to reduce the appearance of wrinkles and improve skin density, according to mesoestetic. The company adds that the formulation contains 15 mg/ml of hyaluronic acid alongside tripeptides and tetrapeptides.
Emily Short, aesthetic training lead at mesoestetic, commented, “mesohyal redenx marks a new era in medical aesthetics where science meets skin biology. By combining advanced biomimetic peptides with deep hydration technology, it delivers a refined, regenerative approach to improving skin density, firmness and vitality.”
